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ABSTRACT
Carbonic anhydrase IX (CAIX) plays an important
role in the growth and survival of tumor cells.
MORC2 is a member of the MORC protein family.
The MORC proteins contain a CW-type zinc finger
domain and are predicted to have the function of
regulating transcription, but no MORC2 target
genes have been identified. Here we performed a
DNA microarray hybridization and found CAIX
mRNA to be down-regulated 8-fold when MORC2
was overexpressed. This result was further con-
firmed by northern and western blot analysis.
Our results also showed that the protected region
4 (PR4) was important for the repression function
of MORC2. Moreover, MORC2 decreased the
acetylation level of histone H3 at the CAIX
promoter. Meanwhile, trichostatin A (TSA) had an
increasing effect on CAIX promoter activity.
Among the six HDACs tested, histone deacetylase
4 (HDAC4) had a much more prominent effect on
CAIX repression. ChIP and ChIP Re-IP assays
showed that MORC2 and HDAC4 were assembled
on the same region of the CAIX promoter. Impor-
tantly, we further confirmed that both proteins are
simultaneously present in the PR4-binding complex.
These results may contribute to understanding the
molecular mechanisms of CAIX regulation.
INTRODUCTION
Carbonic anhydrase IX (CAIX), also called MN or G250,
is a member of the carbonic anhydrase family that
catalyzes the reversible hydration of carbon dioxide
(H2O+CO2,H
++HCO
 
3 ) and as such are vital to
many biological and physical functions. CAIX is a
transmembrane isozyme and has been implicated in the
control of tumor cells growth and survival (1). Because
CAIX expression correlates with lowered O2 tension in
tumors, CAIX is proposed as an intrinsic marker of
hypoxia (2). CAIX may be involved in early gastric
carcinogenesis as CAIX deﬁcient mice show increased
cellular proliferation and develop gastric hyperplasia (3).
And it has been reported that the expression of CAIX
correlates with an extremely poor prognosis in gastric
adenocarcinomas (4). In human malignancy, over-
expression of CAIX is consistently seen in a strikingly
high proportion of carcinomas of the cervix (5) and
clear cell carcinoma of the kidney (6), and, to a lesser
degree, in other types of human tumors, such as carci-
nomas of the breast (7,8), head and neck (9,10), lung
(11) and tumors of the brain (12,13). However, expression
of CAIX is low or even lost in most gastric cancers (14,15).
In addition, a subgroup of gastric cancers retain CAIX
expression in cancer cells at the invasion front, implying
that increased CAIX expression may contribute to
invasion and thus advanced disease and tumor progres-
sion in a subset of gastric cancers (16). Therefore, in order
to understand the roles of CAIX gene expression in the
carcinogenesis and progress of gastric cancer, it is essential
to gain a more intensive insight into the expression control
of this gene.
The promoter of CAIX gene has been characterized and
localized in the region between  173 and +31bp in
respect to the transcription start site (17). Hypoxia acti-
vates CAIX gene transcription through hypoxia inducible
factor-1 (HIF-1), which binds to the hypoxia-response
element (HRE) in the CAIX promoter immediately
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protected regions (PRs) within the CAIX promoter, of
which PR1 and PR2 are the most critical for trans-
criptional activity (17). Transcription factors Sp1/Sp3
are described to up-regulate CAIX by binding to the
PR1 and PR5 position of CAIX promoter (19,20).
HIF-1a and Sp1, in combination with CBP/p300, are
identiﬁed as the crucial elements for CAIX expression in
clear cell renal cell carcinoma (21). Although a repressor
complex, which directly contacts with PR4, is found to
negatively regulate CAIX transcription (17), the composi-
tion of the repressor complex and the repression mecha-
nism remain unknown.
MORC2 (microrchidia 2) is a member of the MORC
protein family characterized by conserved structures
consisting of an ATPase domain, a zinc ﬁnger type
CW domain, a nuclear localization signal (NLS) and
coiled-coil domains. There are four predicted MORC
family proteins (MORC1, MORC2 [KIAA0852,
ZCWCC1], MORC3 [KIAA0136, ZCWCC3, NXP-2]
and MORC4 [ZCWCC2]) in human. The MORC family
proteins belong to CW-domain-containing subfamilies I
(MORC1 and MORC2) or IX (MORC3 and MORC4)
(22). MORC1 is expressed speciﬁcally in male germ cells
(23), whereas MORC2 and MORC3 are ubiquitously
expressed. A recent study has showed that MORC3 regu-
lates p53 activity by localization to a nuclear subdomain
(24). And it is reported that MORC4 is a potential
biomarker as it is highly expressed in a subset of diﬀuse
large B-cell lymphomas (25).
MORC family proteins are conserved in higher
eukaryotes, predicting an important function for them in
the biology of multicellular organisms, however, few
studies have been made to identify the possible molecular
function of MORC family proteins. MORC2 contains a
CW zinc ﬁnger motif and the CW domain is predicted to
play a part in DNA binding and/or promoting protein–
protein interactions, therefore MORC2 may have a role in
gene transcriptional regulation. To search for hitherto
unidentiﬁed MORC2 target genes, we performed a DNA
microarray hybridization (aﬀymetrix). We found CAIX
mRNA to be down-regulated 8-fold when MORC2 was
overexpressed. We also conﬁrmed the result by northern
and western blot analysis, as well as the luciferase reporter
assays. Moreover, we showed that the PR4 in the CAIX
promoter was important for the repression function of
MORC2 on CAIX transcription. In addition, MORC2
decreased the acetylation level of histone H3 at the
CAIX promoter. Meanwhile, trichostatin A (TSA) had
an increasing eﬀect on CAIX promoter activity. Among
the six histone deacetylases (HDACs) tested, histone
deacetylase 4 (HDAC4) had a much more prominent
eﬀect on CAIX repression. Finally, we found that
MORC2 and HDAC4 were assembled on the same
region of CAIX promoter. Importantly, we further con-
ﬁrmed that both proteins are simultaneously present in the
PR4-binding complex. These data provide a basis for
the further investigation into the mechanisms of CAIX
gene regulation.
MATERIALS AND METHODS
Plasmids construction
For the construction of CAIX promoter-driven luciferase
reporter plasmid pGL3-E-CP, the CAIX promoter frag-
ment comprising  173 to +31bp was ampliﬁed by PCR
from human genomic DNA with sense primer 50-GTATTC
GGGGTACCACCTGCCCCTCACTCC-30 and antisense
primer 50-ATCGAGGAAGATCTGGGTGTGTCCCAG
CAC-30. The ampliﬁed fragment was digested with KpnI/
BglII and inserted into the ﬁreﬂy luciferase reporter vector
pGL3-Enhancer (Promega). A series of 50-deleted con-
structs were derived from pGL3-E-CP by PCR. The
sense primers were 50-GTATTCGGGGTACCCTTTGG
TATGGGGGAGA-30 (pGL3-E-C5,  132 to +31bp),
50-GTATTCGGGGTACCGGAGAGGGCACAGGGC
CA-30 (pGL3-E-C4,  107 to +31bp), 50-GTATTCGGG
GTACCCTGTGAGACTTTGGCTCC-30 (pGL3-E-C3,
 71 to+31bp), 50-GTATTCGGGGTACCGGCTTGCT
CCTCCCCCAC-30 (pGL3-E-C2,  45 to +31bp) and
50-GTATTCGGGGTACCCACGTACAGCCCGTACA
C-30 (pGL3-E-C1,  8 to+31bp). The antisense primer
was the same as that used for pGL3-E-CP construction.
For the construction of pcDNA3.1/MORC2, pcDNA3.1/
MORC1 and pcDNA3.1/MORC3, human MORC2,
MORC1 and MORC3 cDNA were obtained from
NIH-MGC (http://mgc.nci.nih.gov) (Invitrogen) by PCR.
The primers were as follows: MORC2 sense primer 50-ATA
GATATTTAGGTACCAAGACGAGAG-30, MORC2
antisense primer 50-CGACCACCAACTCGAGAATGA
AG-30, MORC1 sense primer 50-GTCTACGGGATCCA
TGGACGACAGGTACCCT-30, MORC1 antisense
primer 50-CGGGTCGACTCGAGTTAATTTTCCGAA
GTCTT-30, MORC3 sense primer 50-GTCTACGGGAT
CCATGGCGGCGCAGCCACC-30 and MORC3
antisense primer 50-CGGGTCGACTCGAGTTAAGTA
CTACTGATTTC-30. The ampliﬁed MORC2 fragment
was digested with KpnI/XhoI and inserted into
pcDNA3.1/HisA plasmid (Invitrogen). The ampliﬁed
MORC1 and MORC3 fragments were digested with
BamHI/XhoI and inserted into pcDNA3.1/HisC plasmid
(Invitrogen), respectively. All plasmids were conﬁrmed by
restriction mapping and DNA sequencing analysis.
Plasmids expressing human HDAC1-6 (fused to the
Flag-epitope) were kind gifts from Dr E. Seto (H. Lee
Moﬃtt Cancer Center and Research Institute, Tampa,
FL, USA).
Cell culture, transfections and luciferase assays
Human embryonic kidney (HEK)-293 cells, human gastric
cancer cell lines, BGC-823, MGC-803, SGC-7901, human
colorectal cancer cell lines LS174T and Clone A were
grown in DMEM (Dulbecco’s modiﬁed Eagle’s medium)
containing 10% FBS (fetal bovine serum), 100units/ml
penicillin and 100mg/ml streptomycin. Transient and
stable transfections were performed using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instruc-
tions. For stable transfections, SGC-7901 cells were
transfected with the recombinant vector pcDNA3.1/
MORC2 or the empty (control) vector pcDNA3.1/HisA.
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stable clones. For transient transfections, cells were
cotransfected with the listed constructs. After 24h of
transfections, cells were harvested, washed and lysed in
50–200ml of lysis buﬀer. Luciferase activities were
analyzed using a Promega dual-luciferase reporter assay
system. Fireﬂy luciferase activity was normalized to the
activity of Renilla luciferase control. Relative luciferase
activity was analyzed using the luminometer Lumat LB
9507 (Berthold Technologies, Germany). All the results
represent the means±SD based on at least three indepen-
dent experiments.
Total RNA isolation and northern blot analysis
Total cellular RNA was extracted using a total RNA iso-
lation system (Invitrogen) according to the manufacturer’s
instructions. Twenty microgram of total RNA was
fractionated in a 1.2% agarose–formaldehyde gel and
then transferred to a nylon membrane Hybond-N
(Amersham Biosciences). The probes of CAIX and
MORC2 cDNA labeled with [a-
32P] dCTP were used in
hybridization. rRNAs (28S and 18S) were used to assess
the integrity of the RNA. The blots were routinely
reprobed with human glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) cDNA for RNA loading and
transfer control.
Protein isolation and western blot analysis
Cells were lysed using ice-cold RIPA lysis buﬀer [50mM
Tris/HCl (pH 7.4), 150mM NaCl, 1% Nonidet P-40,
0.25% Na-deoxycholate, 1mM EDTA and protease
inhibitor cocktail] for 15min at 4 C. Total cell extracts
were obtained by sonication and centrifugation. Equal
amounts of denatured proteins were separated by SDS–
PAGE (10% gels) and transferred to a PVDF membrane
(Millipore). The samples were incubated with anti-
MORC2 (Bethyl Laboratories Inc.), anti-His
(GenScript), anti-CAIX (Santa Cruz) or anti-GAPDH
(Kang Chen, as a loading control) antibodies. The
samples were detected using the chemiluminescent detec-
tion system (Pierce Technology).
Gene silencing
Silencing of MORC2 was achieved with an RNA interfer-
ence (RNAi) approach using small interfering RNA
(siRNA) for transient knockdown. The target sequences
for MORC2 were 50-GAAAGCAGAGCACGTAGCAA
GGATT-30 and 50-GAAGAAGACAGAGTCACCCAT
CAAA-30. BGC-823 cells were transfected with 50nM of
either MORC2 siRNAs or non-silencing siRNA (as a
negative control) (Shanghai GeneChem Co. Ltd) using
lipofectamine 2000 (Invitrogen) as recommended by the
manufacturer.
Reverse transcription and quantitative real-time PCR
Total RNA (1mg) was reverse transcribed to cDNA in a
total volume of 20ml using a RT (reverse transcriptase)
reaction kit (Promega). Real-time PCR was performed
using an ABI 7500 real-time PCR system (Applied
Biosystems) according to the manufacturer’s instruction
and SYBR Premix Ex Taq (TaKaRa) as a DNA-
speciﬁc ﬂuorescent dye. PCR was carried out for 40
cycles of 95 C for 10s and 60 C for 40s. Primer sequences
for detection of CAIX mRNA expression were synthesized
as 50-AGATGAGAAGGCAGCACAGAA-30 (sense) and
50-GAAGTGGCATAATGAGCAGGA-30 (antisense).
Primer pairs for detection of MORC2 mRNA expression
were synthesized as 50-TCGGAAGCGGAGTGTC-30
(sense) and 50- CGTGCAGCCCTTTATCT-30 (antisense).
The primers used for analysis of  -actin mRNA were: 50-
TCGTGCGTGACATTAAGGAG-30 (sense) and 50-ATG
CCAGGGTACATGGTGGT-30 (antisense). All the reac-
tions were repeated at least three times. Gene expression
levels were calculated relative to the housekeeping gene
 -actin by using ABI 7500 System SDS software.
ChIP (chromatin immunoprecipitation) and ChIP Re-IP
Transfected SGC-7901 cells were cross-linked with 1%
formaldehyde (ﬁnal concentration) after washing. Cells
were lysed with lysis buﬀer [50mM Tris/HCl (pH 8.1),
10mM EDTA, 1% SDS and protease inhibitor cocktail]
and sonicated on ice, then precleared with protein
A-agarose. Following immunoprecipitation with anti-
acetyl-H3 (Millipore), anti-MORC2 (Bethyl Laboratories,
Inc.) or anti-Flag (Sigma) antibodies, protein complexes
were immunoprecipated and washed in turn with low salt,
high salt, lithium chloride buﬀer and TE buﬀer [10mM
Tris/HCl (pH 8.0) and 1mM EDTA]. After elution and
reverse cross-linking, the puriﬁed DNA was resuspended
in TE buﬀer. DNA samples (2ml) were then ampliﬁed by
PCR. Primer pairs for the CAIX promoter ( 173/+31),
up- and down-stream regions of the CAIX gene were 50-A
CCTGCCCCTCACTCC-30 (CAIX promoter sense), 50-G
GGTGTGTCCCAGCAC-30 (CAIX promoter antisense),
50-CATATCGTGGCAGGCAGTG-30 (upstream sense),
50-CCAGGAAGCAGGTAAAGAGGT-30 (upstream
antisense), 50-TCTGCGTTTGTGACATCGT-30 (down-
stream sense) and 50-GGGACCAGTGTTCAGGGAC-30
(downstream antisense).
For ChIP Re-IP, complexes were eluted from the
primary immunoprecipitation by incubation with 10mM
DTT at 37 C for 30min and diluted 1:50 in buﬀer [1%
Triton X-100, 2mM EDTA, 150mM NaCl, 20mM Tris/
HCl (pH 8.1)] followed by reimmunoprecipitation with
the second antibodies. ChIP Re-IPs of supernatants were
done essentially as were the primary IPs. The PCR primers
for ChIP Re-IPs were the same as those for ChIP assays.
GST-pull down assays
pcDNA3.1/MORC2 was transcripted and translated
in vitro using the TNT-coupled transcription and transla-
tion system (Promega). GST-HDAC4 fusion proteins
prebound to glutathione Sepharose 4B (GE Healthcare)
were incubated with MORC2 proteins and rotated at 4 C
for 3h followed by extensive washing with binding buﬀer.
The bound proteins were then eluted in 30ml2   SDS
loading sample buﬀer and boiled for 5min prior to
centrifugation. Attached proteins were separated by
SDS–PAGE (10% gel), blotted onto PVDF membrane
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chemiluminescence reagents (Amersham) were used for
detection. Ponceau stain indicated the loading amounts
of the GST-fusion proteins.
Immunoprecipitation
HEK-293 cells were transiently transfected with
His-MORC2 and GFP-HDAC4 or GFP empty vectors.
The immunoprecipitation (IP) procedure was performed
using the Protein A Sepharose CL-4B (GE Healthcare).
After 36h transfection, the cells were harvested and
resuspended in IP lysis buﬀer. The cells were lysed for
30min followed by centrifugation at 12000 g for
30min. The supernatants were incubated with mouse
monoclonal anti-GFP antibody overnight at 4 C,
followed by addition of 50ml Protein A agarose beads.
The incubation proceeded for 3h at 4 C. The complexes
were collected by centrifugation followed by extensive
washing by IP lysis buﬀer. Following centrifugation, the
complexes were dissolved in 30ml2   SDS loading sample
buﬀer. Attached proteins were separated by SDS–PAGE
(8% gel), blotted onto PVDF membrane and immuno-
stained using standard procedures.
Electrophoretic mobility shift assays (EMSA)
Nuclear protein extracts from BGC-823 cells were
prepared with NE-PER nuclear and cytoplasmic
Extract reagents (Pierce) and in vitro translated MORC2
were made by in vitro TNT-coupled transcription and
translation system (Promega). The PR4 oligonucleotides
were labeled with the Biotin 50 end DNA Labeling Kit
(Pierce) and hybridized to form duplexes. Gel shift
assays were performed using the Pierce LightShift
Chemiluminescent EMSA Kit (Pierce) with 20fmol
duplex per binding reaction. Competition reactions con-
taining a 50-, 100- or 500-fold molar excess of unlabeled
duplex PR4 were performed. Antibody supershift reac-
tions were performed using anti-MORC2 (Bethyl
Laboratories Inc.) or anti-HDAC4 (Santa Cruz) antibody.
RESULTS
MORC2 down-regulates the mRNA and protein levels
of CAIX
The MORC proteins are predicted to have the function of
regulating transcription (23), but no MORC2 target genes
have been identiﬁed. To search for hitherto unidentiﬁed
MORC2 target genes, we carried out stable transfection
experiment. SGC-7901 cells, which had low endogenous
MORC2 expression (Figure 1A), were stably transfected
with pcDNA3.1 or pcDNA3.1/MORC2 plasmid. Then we
performed a DNA microarray hybridization experiment
using RNA from the two stable-transfected cell lines and
found a lot of MORC2 target genes, most of them were
down-regulated. The genes were involved in a variety of
biological functions including ion transport, lipid metab-
olism, inﬂammatory response, response to hypoxia, etc.
CAIX is one of the genes which are down-regulated
markedly. In order to examine whether MORC2
expression is relative to the expression of CAIX in diﬀer-
ent colorectal and gastric cancer cell lines, we carried out
northern and western blot analysis. Total mRNA was
isolated and equal amounts of mRNA were subjected to
northern blot analysis. The endogenous mRNA level of
MORC2 was high in CloneA, LS174T and BGC-823 cells,
in which CAIX mRNA level was obviously low. Whereas
in SGC-7901 cells, which did not express detectable level
of MORC2 mRNA, the endogenous CAIX mRNA level
was distinctly high (Figure 1A). We performed western
Figure 1. MORC2 down-regulates the mRNA and protein levels of
CAIX.( A) Northern blot analysis of MORC2 and CAIX mRNA
levels in diﬀerent colorectal and gastric cancer cell lines. Total RNA
was isolated and 20mg total RNA was analyzed by northern blot
analysis as described in ‘Materials and methods’ section. GAPDH
mRNA was used to assess the integrity of the RNA and to control
for the RNA loading. (B) Western blot analysis of MORC2 and CAIX
protein levels in diﬀerent colorectal and gastric cancer cell lines. Cells
were lysed as indicated in ‘Materials and methods’ section. Equal
amounts of protein (60mg) were separated by SDS–PAGE and
blotted with anti-MORC2 or anti-CAIX antibodies. The expression
of endogenous MORC2 and CAIX were detected using the ECL
staining method. The expression of MORC2 and CAIX in SGC-7901
cells stable-transfected with pcDNA3.1 or pcDNA3.1/MORC2 were
analyzed by northern blot (C) and western blot analysis (D).  ,
untransfected SGC-7901 cells. (E) Western blot analysis of MORC
family members and CAIX protein levels in SGC-7901 cells transfected
with pcDNA3.1, pcDNA3.1/MORC2, pcDNA3.1/MORC1 or
pcDNA3.1/MORC3.
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northern blot analysis. The result showed that the
protein levels of MORC2 and CAIX in these cells were
similar to their mRNA expression levels (Figure 1B).
Then we conﬁrmed the MORC2-dependent decrease of
the CAIX mRNA and protein levels by northern and
western blot analysis, respectively (Figure 1C and D).
These data suggested that MORC2 down-regulated the
expression of CAIX. In order to know whether other
MORC family members have the same repressive eﬀect
on CAIX expression, we carried out western blot
analysis and found that ectopic expressed MORC1 also
down-regulated CAIX expression. But MORC3 did not
down-regulate the expression of CAIX obviously.
MORC2 down-regulates CAIX promoter activity, mRNA
and protein levels in a dose-dependent manner
In order to elucidate whether the decrease in CAIX
mRNA is dependent on MORC2 as a regulator of tran-
scription, we examined the regulation of the CAIX
promoter. As a reporter, we used the  173 to +31
fragment of the CAIX promoter fused to the luciferase
reporter gene. This region has been shown to be suﬃcient
for the transcriptional induction of CAIX gene in MaTu
and HeLa cells (17). MGC-803 cells were transfected with
the pGL3-E-CP reporter construct and increasing
amounts of MORC2 expression vector. The results
showed that MORC2 down-regulated CAIX promoter
activity in a dose-dependent manner (Figure 2A). To test
the expression of MORC2 after the transfection, we
carried out western blot analysis, at the same time,
CAIX mRNA and protein levels were also examined. As
can be seen in Figure 2B and C, with increasing amounts
of MORC2 expression plasmid transfected, the mRNA
and protein levels of CAIX were decreased. We also per-
formed RT-PCR, real-time PCR and western blot analysis
in SGC-7901 cells. The mRNA and protein levels of CAIX
were reduced with the ectopic MORC2 expression level
enhancing (Figure 2D and E). In sum, these results show
that MORC2 is able to down-regulate the expression of
CAIX in a dose-dependent manner.
Speciﬁc knockdown of MORC2 increases CAIX
expression
To further address the down-regulation of CAIX
by MORC2, we tested whether speciﬁc knockdown
Figure 2. MORC2 down-regulates CAIX promoter activity, mRNA and protein levels in a dose-dependent manner. (A) MGC-803 cells were
transfected with pGL3-E-CP reporter construct (ﬁreﬂy luciferase expression vector), pRL-TK plasmid (renilla luciferase expression vector) and
MORC2 expression vector as indicated. Total DNA of the plasmid was adjusted to the same amount by transfecting pcDNA3.1 empty vector.
After 24h of transfection, the cells were harvested and ﬁreﬂy and renilla luciferase activities were measured using Dual-Luciferase Reporter Assay
System (Promega), with the results expressed as the ratio of ﬁreﬂy to renilla luciferase activity (Fluc/Rluc). The renilla luciferase activity was used as
a control for normalizing the assay. All the results represented means±SD of three independent experiments. *P<0.05, **P<0.01. (B) MGC-803
cells were transfected with the MORC2 expression vector as indicated. After 30h of transfection, the mRNA levels of CAIX were measured by
northern blot analysis. (C) The same transfection experiment as (B), after 30h of transfection, cells were lysed and equal amounts of protein (100mg)
were separated by SDS–PAGE, the protein levels of MORC2 and CAIX were measured by western blot analysis. (D) MORC2 expression vectors
were transiently transfected into SGC-7901 cells as indicated, and the mRNA level was estimated by RT–PCR and real-time PCR analysis. Values
are means±SD (n=3). **P<0.01. (E) SGC-7901 cells were transfected with MORC2 expression vector as indicated, after 30h of transfection,
the protein levels of MORC2 and CAIX were measured by western blot analysis.
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were transfected with siRNAs targeting MORC2 or
non-silencing control. After 24h of transfection,
northern and western blot analysis were carried out to
detect the expression of MORC2 and CAIX using these
cells. The eﬀective knockdown of MORC2 enhanced the
mRNA level of CAIX (Figure 3A), western blot analysis
showed the speciﬁc knockdown of MORC2 increased the
protein level of CAIX (Figure 3B). We also performed
luciferase assays to detect the promoter activity of CAIX
after the expression of MORC2 was knockdown. The
result showed that after the speciﬁc knockdown of
MORC2, the promoter activity of CAIX was elevated
(Figure 3C). All these observations indicate that speciﬁc
knockdown of MORC2 increases CAIX expression.
The PR4 in the CAIX promoter is important for
the suppression function of MORC2 on CAIX
transcription
Five PRs within the CAIX promoter have been identiﬁed
(17), to determine which regions are required for the sup-
pression function of MORC2 on CAIX transcription,
a series of luciferase reporter constructs containing
50-ﬂanking deletions of the CAIX promoter were
generated (Figure 4A) and transiently transfected into
BGC-823 cells. Luciferase activities generated from these
constructs upon transfection were shown in Figure 4B.
Compared to deletion to  132, the deletion to  107 had
an increased luciferase activity, implying that PR4 was a
negative regulatory element (Figure 4B), which is consis-
tent with the obvious observation of another group (17).
Our attention was focused on the association of the
negative element PR4 with the MORC2-mediated
decreasing of CAIX promoter activity. Therefore, we
carried out luciferase assays to test the eﬀect of PR4 on
the CAIX transcriptional inhibition by MORC2. We used
the same luciferase reporters as shown in Figure 4A.
Signiﬁcant decrease of CAIX promoter activity was
observed in pGL3-E-CP and pGL3-E-C5 constructs, but
not in pGL3-E-C4, pGL3-E-C3, pGL3-E-C2 and
pGL3-E-C1, which had not the PR4 (Figure 4C). We
therefore conclude that the PR4 region plays an important
role in the suppression function of MORC2 on CAIX
transcription.
Histone deacetylation is involved in the CAIX
transcriptional repression
Histone deacetylation is one of the best-characterized
covalent modiﬁcations associated with a repressed
chromatin state (26,27). In order to detect the inﬂuence
of MORC2 on the acetylation level of histone H3 at the
CAIX promoter, ChIP assay was carried out. The
chromatin fragments from SGC-7901 cells transfected
with MORC2 expression plasmid or pcDNA3.1 empty
vector were immunoprecipitated with antibody against
acetylated histone H3. Following the isolation of
precipitated DNA, the  173 to +31 region of the CAIX
promoter was ampliﬁed. The result showed that the
acetylation level of histone H3 was markedly decreased
by the transfection of MORC2 (Figure 5A). Furthermore,
inhibition of HDAC activity by TSA, a known HDAC
inhibitor, resulted in the elevation of CAIX promoter
activity (Figure 5B, compare column 3 with 1). Thus,
the activity of CAIX promoter was associated with
HDACs (Figure 5B). We performed the same experiment
in two cell lines, HEK-293 cells and BGC-823 cells, and
obtained similar result as above (Figure 5B). These data
strongly suggest that HDACs play important roles in the
CAIX transcriptional repression. We further tested the
eﬀects of the six HDACs (HDAC1-6) on CAIX gene reg-
ulation. We transfected the pGL3-E-CP plasmid together
with the empty vector or the HDAC constructs expressing
HDAC1-6, respectively. After 24h of transfection,
luciferase activities were measured and normalized to
Renilla activity. The result was shown in Figure 5C,
which indicated that the six HDACs tested exerted
distinct repressive eﬀects on the CAIX promoter activity,
among which HDAC4 had a much more prominent eﬀect
on CAIX repression, bringing about a nearly 3-fold
repression of the promoter activity (Figure 5C). To
further investigate how the endogenous mRNA level of
CAIX was aﬀected by MORC2 and HDAC4, we per-
formed RT-PCR and real-time PCR experiments.
The results showed that HDAC4 was able to inhibit
Figure 3. Speciﬁc knockdown of MORC2 leading to the up-regulation
of CAIX. BGC-823 cells were transfected with siRNAs targeting
MORC2 or non-silencing control. C, untransfected BGC-823 cells,
NC, BGC-823 cells transfected with non-silencing control. (A) After
30h of transfection, the mRNA levels of MORC2 and CAIX were
measured by northern blot analysis. GAPDH mRNA was used to
assess the integrity of the RNA and to control for the RNA loading.
(B) After 30h transfection, the protein levels of MORC2 and CAIX
were measured by western blot analysis. (C) After 24h of transfection,
the cells were transfected with the reporter constructs pGL3-E-CP
(ﬁreﬂy luciferase expression vector) and pRL-TK (renilla luciferase
expression vector), 24h later, the cells were lysed, ﬁreﬂy and renilla
luciferase activities were measured using Dual-Luciferase Reporter
Assay System (Promega). First we got the ratio of ﬁreﬂy to renilla
luciferase activity (Fluc/Rluc, Rluc was used as a control for
normalizing the assay) and then the results were shown as fold induc-
tion relative to that of cells transfected without siRNA. The results
were the means±SD of three individual experiments. *P<0.05.
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MORC2 (Figure 5D). We performed additional luciferase
assays with HDAC4 expression plasmid and CAIX
promoter deletion constructs used in Figure 4A. As can
be seen in Figure 5E, obvious decrease of CAIX promoter
activity was exhibited only in pGL3-E-CP and
pGL3-E-C5 constructs, which had the PR4 region. The
result indicates that HDAC4 probably also works
through the PR4 element similar to MORC2. All these
data demonstrate that histone deacetylation is involved
in the CAIX transcriptional inhibition and PR4 plays an
important role in the CAIX transcriptional repression by
HDAC4.
HDAC4 and MORC2 act in a combinatorial fashion on
the CAIX promoter
In an attempt to test the binding of MORC2 or HDAC4
to the CAIX promoter, we performed two ChIP assays.
SGC-7901 cells were transfected with pcDNA3.1 empty
vector or pcDNA3.1/MORC2 expression plasmid, ChIP
was carried out using antibody against MORC2, followed
by PCR with primers speciﬁc for the CAIX promoter
region. As shown in Figure 6A, binding of MORC2 was
detected at the  173 to +31 region in the CAIX
promoter, but not the more up- or down-stream region
of the CAIX gene. For another ChIP experiment,
SGC-7901 cells were transfected with pcDNA3.1 empty
vector or Flag-HDAC4 expression plasmid, the chromatin
fragments from these cells were immunoprecipitated with
antibody against Flag. Following the isolation of
precipitated DNA, the CAIX promoter were ampliﬁed.
The result showed that HDAC4 was associated with the
CAIX promoter, but not the more up- or down-stream
region of the CAIX gene (Figure 6B). To further
examine whether MORC2 and HDAC4 were assembled
on the same promoter, ChIP Re-IP assays were carried
out. We divided the soluble chromatin derived from
MORC2 and Flag-HDAC4 cotransfected or pcDNA3.1
transfected cells into two aliquots. One was immunopre-
cipitated with anti-Flag antibody followed by release of
the immune complexes and reimmunoprecipitated (Re-IP)
with anti-MORC2 antibody. The other was ﬁrst immuno-
precipitated with anti-MORC2 antibody followed by
release and Re-IP with anti-Flag antibody. The same
Re-IP was also performed on the unbound supernatant
fractions from the primary immunoprecipitation. While
both Flag and MORC2 antibodies were able to immuno-
precipitate the CAIX promoter ( 173/+31) after
cells were cotransfected with MORC2 and HDAC4
(Figure 6C), subsequent supernatant Re-IPs with either
MORC2 antibody or Flag antibody were unable to do
so. On the other hand, subsequent Re-IPs of the eluted
primary immunoprecipitates were able to bind the CAIX
promoter ( 173/+31) (‘bound’ in Figure 6C). Figure 6C
Figure 4. Identiﬁcation of the cis-elements involved in the suppression function of MORC2 on CAIX transcription. (A) Schematic representation of
a series of 50-deleted CAIX promoter/luciferase constructs. The transcription initiation site is indicated by a bent arrow. Numbers indicate base pairs
from the transcription start site. (B) The basal activities of the corresponding constructs in BGC-823 cells. Luciferase activities were normalized to
Renilla activities. The bar is mean±SD from three independent experiments, in duplicate for each construct. (C) The comparison of the eﬀects of
MORC2 on the activities of 50-deleted CAIX promoter/luciferase constructs in BGC-823 cells. BGC-823 cells were transfected with the indicated
constructs and with (the grey bar) or without (the black bar) MORC2. Results are expressed as a percentage of the MORC2-untransfected control
that is taken as 100%. *P<0.05 compared with control.
Nucleic Acids Research,2010, Vol.38, No. 9 2819showed that both HDAC4 and MORC2 were bound to
the CAIX promoter, apparently in the same complex.
In order to show the speciﬁcity of such a co-interaction,
we performed ChIP Re-IP assay with HDAC2 and
MORC2. The result showed that HDAC2 neither
bound the CAIX promoter nor interacted with MORC2
(Figure 6D). These experiments support a model in which
MORC2 and HDAC4 act in a combinatorial fashion on
the CAIX promoter.
MORC2 binds to HDAC4 and both of them bind to the
PR4 region of the CAIX promoter
To test whether MORC2 could physically interact with
HDAC4, in vitro binding study was done using in vitro
Figure 5. Histone deacetylation is involved in the CAIX transcriptional repression. (A) The acetylation level of histone H3 at CAIX promoter ( 173/
+31) was decreased after the overexpression of MORC2. SGC-7901 cells were transfected with 8mg MORC2 expression vector or pcDNA3.1 empty
vector as the control. ChIP was carried out using antibody against acetylated histone H3 (a-AcH3), followed by PCR with primers amplifying the
CAIX promoter region ( 173/+31). (B) HEK-293 cells and BGC-823 cells were transfected with the pGL3-E-CP reporter construct, pRL-TK and
MORC2 or pcDNA3.1 empty plasmid for 6h followed by treatment with or without TSA (200nM) for 24h. Results are shown as fold induction
relative to that of the cells transfected with pGL3-E-CP and pRL-TK, and without treatment of TSA. Values are means±SD (n=3). (C) BGC-823
cells were transfected with pGL3-E-CP plasmid together with HDAC constructs expressing HDAC1-6, respectively. Luciferase activities were
determined and normalized to Renilla activity 24h after transfection. Results are shown as fold induction relative to that of the cells transfected
without HDAC plasmid and are the means±SD from at least three individual experiments. *P<0.05, **P<0.01. (D) MORC2 and HDAC4 were
transiently transfected into BGC-823 cells as indicated, and the mRNA level was estimated by RT-PCR and real-time PCR analysis. Values are
means±SD (n=3), **P<0.01. (E) BGC-823 cells were transfected with CAIX promoter deletion constructs used in Figure 4A and with or without
HDAC4 expression plasmid as indicated. Luciferase activities were determined and normalized to Renilla activity 24h after transfection. Results are
expressed as a percentage of the MORC2-untransfected control that is taken as 100%. *P<0.05 compared with control.
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GST-tagged full-length HDAC4. The results indicated
that MORC2 bound to the full-length HDAC4
(Figure 7A). To conﬁrm the binding of MORC2 and
HDAC4 in vivo, we carried out immunoprecipitation
followed by western blot analysis. We transfected
HEK-293 cells with His-tagged MORC2 and GFP-
tagged HDAC4 or GFP empty vector. The results
indicated that MORC2 and HDAC4 were in the same
complex in vivo (Figure 7B). To identify whether both
MORC2 and HDAC4 bound to the PR4 region, PR4
oligonucleotides were synthesized and labeled with biotin
as the probe. Nuclear extracts from BGC-823 cells were
used. The results showed that PR4 probe formed a
complex with nuclear extracts. The complex was
competed by 50-, 100- or 500-fold molar excess of
unlabeled PR4 (Figure 7C). Further studies showed that
the complex formed was super-shifted with anti-MORC2
or anti-HDAC4 antibody (Figure 7C). PR4 probe also
formed a complex with in vitro transcripted and translated
MORC2 protein. The complex was also competed by
50- or 100-fold molar excess of unlabeled PR4 (Figure
7D). The complex was also super-shifted by antibody
speciﬁc to MORC2 (Figure 7D).
DISCUSSION
MORC2 belongs to the MORC protein family. Although
the biological functions of MORC proteins have remained
poorly understood, studies of the prokaryotic MORCs
and their relatives suggest that their eukaryotic counter-
parts are likely to carry out chromatin remodeling
function (28). MORC2 contains a CW zinc ﬁnger motif
and the CW domain is predicted to play a part in DNA
binding and/or promoting protein–protein interactions
(22), therefore MORC2 may have a role in gene
transcriptional regulation. The main contribution of this
study is the demonstration of the involvement of MORC2
and histone deacetylase 4 in transcriptional control of
CAIX gene in gastric cancer cells.
Previous studies have concentrated on CAIX gene reg-
ulation in non-gastric cancer cells, such as renal cell
Figure 6. ChIP and ChIP Re-IP assays for MORC2 and HDAC4 in association with the CAIX promoter. (A) ChIP assay to examine the binding of
MORC2 to the CAIX promoter. SGC-7901 cells were transfected with 4mg MORC2 expression vector or pcDNA3.1 empty vector as the control.
ChIP was carried out using antibody against MORC2, followed by PCR with primers amplifying the CAIX promoter region ( 173/+31), up- and
down-stream regions of CAIX gene. (B) ChIP assay for detection of the recruitment of HDAC4 to the CAIX promoter. SGC-7901 cells were
transfected with 4mg pcDNA3.1 empty vector or Flag-HDAC4 expression plasmid. ChIP was carried out using antibody against Flag, followed by
PCR with primers amplifying the CAIX promoter region. (C) ChIP Re-IP to examine whether MORC2 and HDAC4 were assembled on the same
promoter. Soluble chromatin was prepared from SGC-7901 cells transfected with MORC2 and HDAC4 or pcDNA3.1 empty vector and divided into
two aliquots. One aliquot was ﬁrst immunoprecipitated with antibody against Flag (1  IP). The supernatant was collected and reimmunoprecipitated
with antibody against MORC2 (Supernatant Re-IP). The other aliquot was ﬁrst immunoprecipitated with antibody against MORC2 (1  IP), followed
by reimmunoprecipitation with antibody against Flag. Similar reciprocal Re-IPs were also performed on complexes eluted from the 1  IPs (Bound
Re-IP). (D) The same ChIP Re-IP experiment as (C) to examine whether MORC2 and HDAC2 were assembled on the same promoter. SGC-7901
cells were transfected with MORC2 and Flag-HDAC2 or pcDNA3.1 empty vector. The antibodies used were against MORC2 and Flag.
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osteosarcoma Saos-2 cells, etc. (21,29), and focused on
the identiﬁcation of cis-acting elements and their cognate
transcription factors (cofactors) that activated CAIX gene.
Six cis-acting elements were functionally characterized in
the CAIX promoter, they are HRE and ﬁve PRs, among
which ﬁve have a positive and one has a negative inﬂuence
on promoter activity (17). HRE is a positive regulatory
element, which activated by the hypoxia-inducible factor
(HIF). Two of the positive CAIX cis-acting elements, PR1
and PR5, bind Sp1/Sp3 factors (19–21). The PR2 and PR3
are also positive regulatory elements, which bind AP1
and proteins from nuclear extracts respectively (17,19).
Although the PR4 has a negative eﬀect on the CAIX
promoter activity, the presumed repressor binding PR4
has not been identiﬁed. In the present study, the
transcriptional regulation of CAIX gene in gastric cancer
cells was examined. We found that MORC2 repressed the
mRNA and protein levels, as well as the promoter activity
of CAIX in a dose-dependent manner in gastric cancer
cells (Figure 2). And this result was also proved by the
speciﬁc knockdown of MORC2 (Figure 3). The luciferase
assays using the deletion mutants showed that the PR4
region was important for the suppression function of
MORC2 on CAIX transcription (Figure 4).
Epigenetic modiﬁcations, such as methylation of CpG
sites in the proximity of promoters and/or post-
translational modiﬁcations of histones, play a signiﬁcant
role in the control of gene expression, presumably by
limiting access of transcription factors to cis-acting
elements. Histone deacetylation is one of the best-
characterized covalent modiﬁcations associated with a
repressed chromatin state (26). The methylation status
of the  74 and  6 CpG sites in the CAIX promoter has
been reported to negatively correlate with CAIX expres-
sion in renal cells (30–33), but no one has studied the
histone acetylation status at the CAIX promoter. The
study presented here showed that the acetylation level of
histone H3 was markedly decreased by the overexpression
of MORC2 (Figure 5A). Thus, we presumed that histone
deacetylase participated in the regulation of CAIX gene
transcription. And this presumption was further sup-
ported by the result that inhibition of HDAC activity by
TSA resulted in the elevation of CAIX promoter activity
(Figure 5B, compare column 3 with 1).
Among the six human HDACs tested in the present
study, HDAC4 was found to be much more eﬀective in
suppressing the transcriptional activity of the CAIX
promoter (Figure 5C). HDAC1-6 represents the enzymes
belonging to two diﬀerent classes, which have distinct
features in structure and exert diﬀerent functions.
Compared with Class I members, Class II HDACs,
including HDAC4, 5, 6 and 7, display more speciﬁc
responses to various signaling molecules. Such speciﬁcities
allow speciﬁc target genes to be regulated by individual
Class II HDAC members in a type-speciﬁc pattern.
We have demonstrated that over-expression of HDAC4
resulted in markedly reduction of CAIX promoter
activity and mRNA level (Figure 5C and D), suggesting
that members of Class II HDACs might be more eﬀective
in inhibiting transcription of the CAIX gene.
As co-repressors, HDACs require speciﬁc transcription
factors for recruiting them to target DNA elements for
regulatory functions. In this study, we showed that both
of MORC2 and HDAC4 were associated with the CAIX
promoter by ChIP assays (Figure 6A and B). We also
described experimental results to show that MORC2
and HDAC4 were assembled on the same promoter
(Figure 6C). We performed additional ChIP Re-IP exper-
iment to prove the speciﬁcity of such a co-interaction
Figure 7. MORC2 binds to HDAC4 and both of them bind to the PR4
region of the CAIX promoter. (A) For GST pull-down assay, GST or
GST fusion proteins were incubated with MORC2 protein in vitro
translated. Bound proteins were subjected to SDS–PAGE and
western blot with anti-MORC2 antibody. (B) For the immunopre-
cipitation assay, cell lysates were immunoprecipitated by anti-GFP
antibody, and precipitates were immunoblotted with anti-His
antibody. The expression were checked using 20mg of total cell lysate
(TCL) blotted with the indicated antibodies (bottom panels). (C)
EMSA was performed with nuclear extracts from BGC-823 cells and
the PR4 oligonucleotide (*PR4) labeled with biotin. Lane 1 is *PR4
probe without nuclear extracts. The binding complexes were competed
by 50-, 100- or 500-fold molar excess of unlabeled PR4, respectively,
and supershifted by anti-MORC2 or anti-HDAC4 antibody. NS,
non-speciﬁc; SS, super-shift; *PR4, PR4 probe labeled with biotin;
PR4, unlabeled PR4. (D) EMSA was performed with in vitro translated
MORC2 protein using a TNT quick coupled transcription-translation
system (Promega) and PR4 oligonucleotide (*PR4) labeled with biotin.
The binding complexes were competed by 50- or 100-fold molar excess
of unlabeled PR4, respectively, and super-shifted by anti-MORC2
antibody.
2822 Nucleic Acids Research, 2010,Vol.38, No. 9(Figure 6D). In addition, the in vitro and in vivo interac-
tion of MORC2 and HDAC4 was conﬁrmed by GST-pull
down and IP experiments (Figure 7A and B). Further-
more, we performed EMSA with PR4 and proved by
super-shift that both proteins were simultaneously
present in the PR4-binding complex (Figure 7C and D).
HDAC4 is often found to form multisubunit complex with
other corepressors, such as N-CoR etc, to regulate the
transcription of target genes (34). Our ﬁndings indicated
that MORC2 and HDAC4 were in the inhibitory complex
to suppress the expression of the CAIX gene. Further
studies are needed to identify other corepressors which
might form a complex with HDAC4 to inhibit the tran-
scription of the CAIX gene. Based on the previous knowl-
edge, as well as ﬁndings from this study, we propose a
hypothesized model in which MORC2 binds the PR4 in
the CAIX promoter, and recruits HDAC4 that decreases
the acetylation level of histone H3 at the CAIX promoter,
leading to a closed chromatin structure and thus the
transcriptional repression of CAIX gene (Figure 8).
The exact molecular mechanisms of gastric tumorige-
nesis are still unclear. The studies in CAIX knockout
mice have indicated that CAIX is an important factor in
gastric morphogenesis and homeostasis of the gastric epi-
thelium possibly acting through the control of cell diﬀer-
entiation and proliferation (3). Moreover, it has been
reported that the expression of CAIX correlates with an
extremely poor prognosis in gastric adenocarcinomas (4).
CAIX was highly expressed in the normal gastric mucosa
and the expression declined in carcinomas with less diﬀer-
entiation (14). Till now, few studies have been given to
clariﬁcation the mechanisms of CAIX expression regula-
tion in gastric cancer cells. Our ﬁndings may help to
achieve a better understanding of the CAIX expression
control in gastric cancer cells.
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